Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
8h agoDelivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
9h agoRefers to Item 7 on the agenda: Report on the audit of the consolidated financial statements of Grupa Kęty SA
11h agoThe 4th BOCHK Science and Technology Innovation Prize Award Ceremony Concludes with Great Success
18h agoBuffalo Potash Files Annual Information Form and New Technical Report
19h agoIonik Announces 30-Day Extension of Senior Debt Facility
Xbiotech Inc. logo

Xbiotech Inc.

About

2.43USD-0.05 -2.02%
Closed • Updated at 22:09 GMT+00:00
Market Cap$74.09M
Volume15.2K
Beta1.10
RSI46.44
Health TechnologyBiotechnology

Xbiotech Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Jun 18 2024
XBiotech Results from Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treatment for Advanced Pancreatic Cancer
Jan 4 2024
XBiotech to Begin Constructing New R&D Facility on its 48-acre Campus
Sep 26 2023
XBiotech Announces Enrollment Completion of Phase I Clinical Trial for Hutrukin, a Novel Candidate Therapy for Stroke
Aug 30 2023
XBiotech Announces Enrollment Completion of Phase II, Placebo Controlled, Multicenter Study for Natrunix in Pancreatic Cancer
Aug 8 2023
XBiotech Announces First Patient Begins Novel Natrunix Therapy in Phase II Rheumatoid Arthritis (RA) Clinical Trial

Community Chat

Ask AI

Try asking
6ix6ixAIEvents